.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Baxter
McKinsey
Dow
Teva
Cerilliant
Healthtrust
Johnson and Johnson
Chubb
Covington

Generated: July 21, 2017

DrugPatentWatch Database Preview

Ganirelix acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ganirelix acetate and what is the scope of ganirelix acetate patent protection?

Ganirelix acetate
is the generic ingredient in one branded drug marketed by Organon Usa Inc and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ganirelix acetate has six patent family members in seven countries.

There are four drug master file entries for ganirelix acetate. One supplier is listed for this compound.

Summary for Generic Name: ganirelix acetate

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list4
Suppliers / Packagers: see list1
Clinical Trials: see list935
Drug Prices:see low prices
DailyMed Link:ganirelix acetate at DailyMed

Pharmacology for Ingredient: ganirelix acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 1999RXYesYes6,653,286► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ganirelix acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 19994,801,577► Subscribe
Organon Usa Inc
GANIRELIX ACETATE
ganirelix acetate
INJECTABLE;INJECTION021057-001Jul 29, 19995,767,082► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ganirelix acetate

Country Document Number Estimated Expiration
Spain2247710► Subscribe
Australia8727798► Subscribe
European Patent Office0994718► Subscribe
World Intellectual Property Organization (WIPO)9858657► Subscribe
Austria302018► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: GANIRELIX ACETATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00C/030Belgium► SubscribePRODUCT NAME: GANIRELIX; REGISTRATION NO/DATE: EU/1/00/130/001 20000518
C/GB00/024United Kingdom► SubscribePRODUCT NAME: GANIRELIX OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/130/001 20000517; UK EU/1/00/130/002 20000517
00016Netherlands► SubscribePRODUCT NAME: GANIRELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517
/2000Austria► SubscribePRODUCT NAME: GANIRELIX ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON; REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Medtronic
Teva
Citi
US Army
Dow
Baxter
Federal Trade Commission
UBS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot